Highmark Commercial Medical Policy - Delaware |
Medical Policy: | S-184-006 |
Topic: | Gender Reassignment Surgery |
Section: | Surgery |
Effective Date: | March 5, 2018 |
Issue Date: | March 5, 2018 |
Last Reviewed: | October 2016 |
Gender reassignment surgery (GRS), either as a male-to-female (MTF) transition or as a female-to-male (FTM) transition, consists of medical and surgical treatments that change primary sex characteristics for individuals with gender dysphoria or gender identity disorder who wish to make a permanent transition. |
This policy is designed to address medical guidelines that are appropriate for the majority of individuals with a particular disease, illness, or condition. Each person's unique clinical circumstances may warrant individual consideration, based on review of applicable medical records.
Policy Position Coverage is subject to the specific terms of the member’s benefit plan. |
Delaware Mandate:
(18 Delaware Code Section 2304(22)): Prohibits discrimination by an insurer on the basis of an individual’s gender identity. Gender Identity is defined as an individual’s gender appearance, expression or behavior regardless of the individual’s assigned sex at birth. Delaware Department of Insurance Bulletin 86, effective March 23, 2016, prohibits the denial, exclusion or limitation of coverage for medically necessary services, at determined by a medical provider in consultation with the individual, and based on the individual’s gender identity if the service would be covered for another individual under such contract of insurance. Coverage exclusions related to medically necessary surgeries or treatments related to gender transition or related services for gender dysphoria or gender identity disorder is a violation of 18 Delaware Code Section 2304. Determinations of medical necessity, eligibility and prior authorization requirements for diagnoses related to an insured’s gender identity must be based on current medical standards established by nationally recognized transgender health medical experts.
GRS may be considered medically necessary when ALL of the following are met:
* At least one (1) letter must be a comprehensive report. Two (2) separate letters or one (1) letter with two (2) signatures is acceptable. One (1) letter from a Master’s degree mental health professional is acceptable if the second letter is from a psychiatrist or Ph.D. (clinical psychologist.).
When ALL of the above criteria are met, the following breast/genital surgeries may be considered medically necessary for the following indications:
MTF:
Note: Although not a requirement, it is recommended that MTF undergo feminizing hormone therapy (minimum 12 months) prior to breast augmentation surgery. The purpose is to maximize breast growth in order to obtain better surgical (aesthetic) results.
FTM:
Note: Penile prosthesis surgery is typically performed at stage two (2) or three (3) of a multi-stage phalloplasty (a minimum of nine (9) months following stage one (1)).
The following procedures that may be performed as a component of a gender reassignment are considered cosmetic and, therefore, non-covered (this is not an all-inclusive list):
Preventive Medicine GRS
Please refer to the member specific benefit plan for screenings (e.g., mammogram, routine gynecological examination, pap smear).
Preventive services are subject to the terms of the member’s individual or group customer benefit.
Refer to medical policy S-28 Cosmetic Surgery vs. Reconstructive Surgery for additional information. |
Place of Service: Inpatient/Outpatient |
The policy position applies to all commercial lines of business |
Denial Statements |
Outpatient HCPCS (C Codes) |
C1813 C2622 |
Links |
10/2016 Revised criteria for Gender Reassignment Surgery